We were able to demonstrate the ability of the scDb to efficiently redirect T cells against TRAIL-R2-expressing ovarian cancer cells, simply adding the soluble scDb to malignant ascites and thus mimicking a real human in vivo situation. This evidence concerns the gene TNFRSF10B and ovarian cancer.